Shandong Green Leaf Natural Medicine Research and Development

Shandong Green Leaf Natural Medicine Research and Development is a specialized research subsidiary of Luye Pharma Group, focused on the discovery and development of natural-origin pharmaceuticals and the modernization of traditional Chinese medicine (TCM). The company is best known for developing Xuezhikang, a natural lipid-regulating agent derived from red yeast rice that has achieved significant commercial success in China and international markets. Its R&D efforts span multiple therapeutic areas, including cardiovascular health, oncology, and central nervous system disorders. By leveraging advanced extraction and formulation technologies, the company aims to bridge the gap between traditional natural remedies and modern evidence-based medicine. The entity operates as a core component of Luye Pharma's innovation ecosystem, contributing to a robust pipeline of small molecules and natural products.